SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027708
Filing Date
2018-11-07
Accepted
2018-11-07 07:11:20
Documents
43
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q reta-10q_20180930.htm 10-Q 1386607
2 EX-31.1 reta-ex311_7.htm EX-31.1 18678
3 EX-31.2 reta-ex312_8.htm EX-31.2 18601
4 EX-32.1 reta-ex321_9.htm EX-32.1 10195
5 EX-32.2 reta-ex322_6.htm EX-32.2 10180
  Complete submission text file 0001564590-18-027708.txt   3618058

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT reta-20180930.xml EX-101.INS 489012
7 XBRL TAXONOMY EXTENSION SCHEMA reta-20180930.xsd EX-101.SCH 30590
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE reta-20180930_cal.xml EX-101.CAL 31997
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE reta-20180930_def.xml EX-101.DEF 117117
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE reta-20180930_lab.xml EX-101.LAB 245730
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE reta-20180930_pre.xml EX-101.PRE 180698
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 181164683
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1